Improving HPV vaccination recommendations for young women with HIV in Malawi
Kupewa: Optimizing strategies to implement provider recommendation of HPV vaccination for adolescent girls and young women with HIV in Malawi
This study is all about finding better ways to help young girls and women aged 9-24 living with HIV in Malawi get the HPV vaccine, which can help prevent cancer, by encouraging doctors to recommend it more often.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11001376 on NIH RePORTER |
What this research studies
This research focuses on enhancing the uptake of HPV vaccinations among adolescent girls and young women aged 9-24 living with HIV in Malawi. It aims to identify and optimize strategies that encourage healthcare providers to recommend the HPV vaccine, which is crucial for cancer prevention. By utilizing frameworks that address behavioral and social factors, the project seeks to implement effective recommendations and assess their sustainability over time. The ultimate goal is to improve vaccination rates in a resource-constrained setting where access to healthcare is limited.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescent girls and young women aged 9-24 living with HIV in Malawi.
Not a fit: Patients outside the age range of 9-24 or those not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase HPV vaccination rates among young women with HIV, leading to reduced cervical cancer incidence.
How similar studies have performed: Similar research has shown that clinician recommendations can effectively increase vaccination rates, suggesting a promising approach for this project.
Where this research is happening
New York, United States
- New York University — New York, United States (Active)
Researchers
- Principal investigator: Moucheraud, Corrina — New York University
- Study coordinator: Moucheraud, Corrina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.